Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods to regulate Renalase in the treatment of cancer

Compositions and methods to regulate Renalase in the treatment of cancer

US Patent 12152085 · Granted Nov 26, 2024

Estimated economic value: $107,769,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cell culture platform for single cell sorting and enhanced reprogramming of iPSC2025
Minimal volume reprogramming of mononuclear cells2025
Methods for measuring Renalase2025
Anti-renalase antibodies for the treatment and prevention of diseases and disord2025
Compositions and methods to regulate Renalase in the treatment of cancer2022
Compositions and methods to regulate Renalase in the treatment of cancer2022
Compositions and methods to regulate Renalase in the treatment of cancer2022
Compositions and methods to regulate Renalase in the treatment of cancer2022
Reprogramming methods and cell culture platforms2022
Compositions and methods for treating and preventing pancreatitis, renal injury 2021
Minimal volume reprogramming of mononuclear cells2021
Compositions and methods for detecting, treating and preventing diseases and dis2021